UK screening programmes — MCQs

10 questions

A 43-year-old woman presents asking about strategies to reduce her breast cancer risk. Her mother was diagnosed with breast cancer at age 48 and her maternal aunt at age 52. She has no personal history of breast disease. Clinical examination is normal. She takes the combined oral contraceptive pill and drinks 10 units of alcohol weekly. Her BMI is 26 kg/m². After appropriate genetic assessment, she is found not to carry BRCA mutations. Which lifestyle modification would provide the greatest reduction in her breast cancer risk?

A 66-year-old man attends after receiving an NHS AAA screening result showing an infrarenal aortic diameter of 4.8 cm. He is asymptomatic. He smokes 15 cigarettes daily, has hypertension treated with ramipril, and his BP is 138/82 mmHg. What is the most appropriate surveillance and management plan?

A 55-year-old woman with a BMI of 32 kg/m² attends for weight management support. She has tried multiple diets without sustained success. She has no other medical conditions. She asks about pharmacological options for weight loss. According to NICE guidance, what is the threshold for considering orlistat in this patient?

A 71-year-old woman with type 2 diabetes for 18 years attends for review. Her diabetic eye screening report from 2 weeks ago shows 'proliferative diabetic retinopathy with new vessels at disc in left eye'. She reports no visual symptoms. Her HbA1c is 72 mmol/mol, BP 156/88 mmHg. She has not yet received any ophthalmology appointment. What is the most appropriate action?

A 29-year-old woman attends for preconception counselling. She is planning pregnancy with her partner. She had one previous pregnancy 3 years ago with uncomplicated vaginal delivery. She takes no regular medications and has no chronic conditions. Which of the following screening tests should be offered before conception?

A 46-year-old man attends for cardiovascular risk assessment. He drinks 6 pints of beer (4.5% ABV) on Friday and Saturday nights. He works in construction and is physically active. BMI is 27 kg/m², BP 134/84 mmHg. He asks about reducing his drinking. According to current UK Chief Medical Officers' guidelines, how many units of alcohol does he consume weekly?

A 31-year-old woman attends with her cervical screening result showing hrHPV positive with low-grade dyskaryosis. She is 8 weeks pregnant with her second child. She had a normal screening result 3 years ago. What is the most appropriate management?

A 64-year-old man returns for discussion of his NHS bowel cancer screening result. His FIT result is 78 µg Hb/g faeces. He has no symptoms, no family history of colorectal cancer, and examination is unremarkable. He takes aspirin 75 mg daily for previous myocardial infarction. What is the most appropriate management?

A 58-year-old woman attends for NHS Health Check. She has a BMI of 28 kg/m², BP 128/82 mmHg, and smokes 10 cigarettes daily. Bloods show total cholesterol 5.2 mmol/L, HDL 1.4 mmol/L, HbA1c 39 mmol/mol. Her QRISK3 score is 8.5%. She is motivated to improve her health. What is the most evidence-based lifestyle intervention to offer?

Q10

A 67-year-old man with type 2 diabetes for 15 years attends for review. His diabetic retinopathy screening report shows 'moderate non-proliferative diabetic retinopathy with diabetic maculopathy' in both eyes. His HbA1c is 68 mmol/mol and BP 142/86 mmHg. What is the most appropriate action regarding his eye care?

UK screening programmes UK Medical PG Practice Questions and MCQs

Question 1: A 43-year-old woman presents asking about strategies to reduce her breast cancer risk. Her mother was diagnosed with breast cancer at age 48 and her maternal aunt at age 52. She has no personal history of breast disease. Clinical examination is normal. She takes the combined oral contraceptive pill and drinks 10 units of alcohol weekly. Her BMI is 26 kg/m². After appropriate genetic assessment, she is found not to carry BRCA mutations. Which lifestyle modification would provide the greatest reduction in her breast cancer risk?

A. Stopping the combined oral contraceptive pill
B. Reducing alcohol intake to below 5 units per week (Correct Answer)
C. Achieving and maintaining BMI <25 kg/m² through weight loss
D. Undertaking regular vigorous physical activity 150 minutes weekly
E. Adopting a plant-based Mediterranean diet low in processed foods

Explanation: ***Reducing alcohol intake to below 5 units per week*** - There is a well-established **dose-response relationship** between alcohol consumption and breast cancer risk, where each unit consumed per day increases risk by approximately **7-10%**. - Reducing consumption from 10 units to below 5 units per week represents a significant risk reduction that is more impactful than other lifestyle changes in a **pre-menopausal** woman with a modest BMI and moderate alcohol intake. *Stopping the combined oral contraceptive pill* - While the **combined oral contraceptive pill (COCP)** is associated with a small relative risk increase (RR ~1.2), this risk is transient and **returns to baseline** 10 years after cessation. - The absolute risk reduction from stopping the pill in a 43-year-old is generally lower than that achieved through significant **alcohol modification**. *Achieving and maintaining BMI <25 kg/m² through weight loss* - Elevated **BMI** is primarily a significant risk factor for **post-menopausal** breast cancer due to peripheral aromatization of androgens in adipose tissue. - In **pre-menopausal** women like this patient, the association between obesity and breast cancer is less pronounced, and her current BMI of 26 kg/m² is only **borderline overweight**. *Undertaking regular vigorous physical activity 150 minutes weekly* - **Physical activity** provides a modest reduction in risk (approx. 10-20%), largely mediated through secondary effects like **weight management** and hormonal regulation. - While beneficial for overall health, the magnitude of specific breast cancer risk reduction is typically less than that achieved by **halving alcohol intake**. *Adopting a plant-based Mediterranean diet low in processed foods* - Although a **Mediterranean diet** is associated with lower overall cancer mortality and improved cardiovascular health, its specific impact on breast cancer risk is less clinically proven than **alcohol restriction**. - Dietary changes are often recommended as part of a holistic approach but do not show the same **linear correlation** with risk reduction as limiting alcohol.

Question 2: A 66-year-old man attends after receiving an NHS AAA screening result showing an infrarenal aortic diameter of 4.8 cm. He is asymptomatic. He smokes 15 cigarettes daily, has hypertension treated with ramipril, and his BP is 138/82 mmHg. What is the most appropriate surveillance and management plan?

A. Repeat ultrasound in 12 months and reinforce smoking cessation
B. Repeat ultrasound in 3 months and refer to vascular surgery (Correct Answer)
C. Immediate referral to vascular surgery for consideration of intervention
D. Repeat ultrasound in 6 months and optimize cardiovascular risk factors
E. CT angiography for surgical planning and urgent vascular referral

Explanation: ***Repeat ultrasound in 3 months and refer to vascular surgery***- Aneurysms between **4.5 cm and 5.4 cm** are classified as medium-sized and require **3-monthly ultrasound surveillance** according to NICE and NHS guidelines.- Patients with a medium AAA must be **referred to vascular surgery** for assessment, risk factor management, and to establish a pathway if the aneurysm reaches the surgical threshold.*Repeat ultrasound in 12 months and reinforce smoking cessation*- **Annual surveillance** is only indicated for small aneurysms measuring between **3.0 cm and 4.4 cm**.- While **smoking cessation** is vital for all AAA patients, 12-month monitoring is insufficient for a 4.8 cm aneurysm.*Immediate referral to vascular surgery for consideration of intervention*- Surgical intervention is generally only considered when the aneurysm is **asymptomatic and ">=5.5 cm"**, or if there is rapid growth ( ">1 cm per year" ).- This patient is **asymptomatic** and measures 4.8 cm, meaning the risks of elective surgery currently outweigh the risk of rupture.*Repeat ultrasound in 6 months and optimize cardiovascular risk factors*- **6-monthly surveillance** is not a standard interval in the UK AAA screening program; intervals are either 12 months (small) or 3 months (medium).- While **blood pressure control** (target "<140/90 mmHg" ) and statins are necessary, the monitoring timeline here is clinically inappropriate for the aneurysm size.*CT angiography for surgical planning and urgent vascular referral*- **CT angiography** is reserved for pre-operative planning once the decision to intervene (threshold ">=5.5 cm" ) has been made.- **Urgent referral** (within 2 weeks) is required for large aneurysms ( ">=5.5 cm" ), whereas a medium-sized aneurysm follows a standard referral pathway.

Question 3: A 55-year-old woman with a BMI of 32 kg/m² attends for weight management support. She has tried multiple diets without sustained success. She has no other medical conditions. She asks about pharmacological options for weight loss. According to NICE guidance, what is the threshold for considering orlistat in this patient?

A. BMI ≥25 kg/m² with commitment to dietary changes
B. BMI ≥28 kg/m² with obesity-related comorbidities
C. BMI ≥30 kg/m² with commitment to dietary and lifestyle changes (Correct Answer)
D. BMI ≥32 kg/m² after failed conservative management
E. BMI ≥35 kg/m² or BMI ≥30 kg/m² with comorbidities

Explanation: ***BMI ≥30 kg/m² with commitment to dietary and lifestyle changes*** - According to **NICE guidelines**, orlistat is indicated for adults with a **BMI of 30 kg/m² or more** as a primary threshold, even in the absence of comorbidities. - The prescription of orlistat must always be part of a comprehensive weight management program that includes **dietary modification**, increased physical activity, and **behavioral support**. *BMI ≥25 kg/m² with commitment to dietary changes* - A **BMI of 25 kg/m²** signifies **overweight**, for which pharmacological interventions like orlistat are not typically recommended by NICE. - Management at this stage primarily focuses on **lifestyle modifications**, including diet and exercise, without drug therapy. *BMI ≥28 kg/m² with obesity-related comorbidities* - Orlistat can be considered at a **BMI of 28 kg/m² or more** but specifically requires the presence of **obesity-related comorbidities**, such as type 2 diabetes or hypertension. - The patient in this scenario has **no other medical conditions**, meaning this specific threshold does not apply to her. *BMI ≥32 kg/m² after failed conservative management* - While the patient's BMI is 32 kg/m², this specific value is not the **minimum NICE threshold** for initiating orlistat, which is **BMI ≥30 kg/m²**. - Adhering to the established guidelines ensures appropriate and timely access to pharmacological support for eligible individuals. *BMI ≥35 kg/m² or BMI ≥30 kg/m² with comorbidities* - This threshold is generally more aligned with the criteria for referral to **bariatric surgery** rather than the initial prescription of orlistat. - Applying this higher criterion would unnecessarily delay pharmacological intervention for patients who meet the lower, more appropriate threshold for orlistat.

Question 4: A 71-year-old woman with type 2 diabetes for 18 years attends for review. Her diabetic eye screening report from 2 weeks ago shows 'proliferative diabetic retinopathy with new vessels at disc in left eye'. She reports no visual symptoms. Her HbA1c is 72 mmol/mol, BP 156/88 mmHg. She has not yet received any ophthalmology appointment. What is the most appropriate action?

A. Contact ophthalmology to confirm urgent referral has been received and processed (Correct Answer)
B. Reassure that ophthalmology will contact her within 2 weeks of screening report
C. Arrange repeat diabetic eye screening in 3 months to monitor progression
D. Refer urgently to ophthalmology via GP pathway in case screening referral was missed
E. Optimize glycaemic and blood pressure control and wait for screening programme referral

Explanation: ***Contact ophthalmology to confirm urgent referral has been received and processed***- **Proliferative diabetic retinopathy (PDR)** with **new vessels at the disc (NVD)** is a sight-threatening condition that requires an **urgent referral** and treatment within **2 weeks**.- Since the patient has not received an appointment after 2 weeks, active verification is necessary to prevent **permanent vision loss** due to potential administrative or system failures.*Reassure that ophthalmology will contact her within 2 weeks of screening report*- Passive reassurance is unsafe because the **2-week target** for assessment has already been reached without the patient being contacted.- Relying solely on the screening program's automation may lead to delays in treating high-risk **neovascularization**.*Arrange repeat diabetic eye screening in 3 months to monitor progression*- Repeat screening is contraindicated once **referable retinopathy** is identified; the screening process has already served its purpose of detection.- Delayed treatment of PDR increases the risk of **vitreous hemorrhage** and **tractional retinal detachment**.*Refer urgently to ophthalmology via GP pathway in case screening referral was missed*- Sending a duplicate referral via the GP pathway can cause **administrative confusion** and may not be as direct as contacting the department regarding the existing screening referral.- The priority is to confirm the status of the **integrated screening-to-treatment pathway** specifically designed for these cases.*Optimize glycaemic and blood pressure control and wait for screening programme referral*- While **HbA1c** and **blood pressure optimization** are vital for long-term management, they do not replace the need for immediate **panretinal photocoagulation** or other specialist interventions.- Waiting indefinitely for a system-triggered referral when a critical deadline has passed places the patient at significant risk of **sudden blindness**.

Question 5: A 29-year-old woman attends for preconception counselling. She is planning pregnancy with her partner. She had one previous pregnancy 3 years ago with uncomplicated vaginal delivery. She takes no regular medications and has no chronic conditions. Which of the following screening tests should be offered before conception?

A. Rubella immunity only, as other infections are tested in pregnancy (Correct Answer)
B. No infectious disease screening needed as she had testing in previous pregnancy
C. Rubella immunity, HIV, hepatitis B, and syphilis serology
D. Full sexually transmitted infection screen including chlamydia and gonorrhoea
E. HIV and syphilis testing only if high-risk factors identified

Explanation: ***Rubella immunity only, as other infections are tested in pregnancy*** - Identifying **rubella immunity status** preconception is vital because the **MMR vaccine** is a live vaccine and cannot be administered during pregnancy due to potential teratogenic risks. - Routine screening for HIV, hepatitis B, and syphilis is standard practice at the **antenatal booking appointment** (usually in the first trimester), rather than preconception, as infection status can change. *No infectious disease screening needed as she had testing in previous pregnancy* - **Immunity** or **infection status** can change over time; for instance, rubella immunity can wane, and new exposures to other pathogens may have occurred since the last delivery. - National guidelines recommend reassessment of **vaccination history** and immunity for every planned pregnancy to ensure optimal fetal protection. *Rubella immunity, HIV, hepatitis B, and syphilis serology* - While all are important, testing for HIV, hepatitis B, and syphilis is specifically timed for the **first trimester** to align with established antenatal management pathways and optimize timing for interventions. - Universal preconception screening for all these infections is not typically recommended unless specific **clinical risk factors** are identified during the consultation, whereas rubella is universally recommended. *Full sexually transmitted infection screen including chlamydia and gonorrhoea* - Broad STI screening for **chlamydia and gonorrhoea** is not a universal preconception requirement for asymptomatic women in low-risk groups, as this patient appears to be. - These tests are generally reserved for patients presenting with **symptoms** or those with a high-risk sexual history, rather than being part of routine preconception screening. *HIV and syphilis testing only if high-risk factors identified* - This option incorrectly omits **rubella screening**, which is the primary infectious disease intervention universally recommended for all women seeking preconception care. - Regardless of identified high-risk factors, HIV and syphilis are still offered to all pregnant women as part of the **routine antenatal screening program** once pregnancy is confirmed.

Question 6: A 46-year-old man attends for cardiovascular risk assessment. He drinks 6 pints of beer (4.5% ABV) on Friday and Saturday nights. He works in construction and is physically active. BMI is 27 kg/m², BP 134/84 mmHg. He asks about reducing his drinking. According to current UK Chief Medical Officers' guidelines, how many units of alcohol does he consume weekly?

A. 14 units
B. 24 units
C. 30.6 units (Correct Answer)
D. 36 units
E. 42 units

Explanation: ***30.6 units***- Alcohol units are calculated using the formula: **Volume (ml) × ABV (%) / 1000**. One UK pint is **568 ml**, making one 4.5% ABV beer equal to **2.556 units**.- The patient consumes 12 pints per week (6 on Friday and 6 on Saturday), so total consumption is **12 × 2.556 = 30.672 units**, which is significantly above the **UK Chief Medical Officers' low-risk limit of 14 units** weekly.*14 units*- This represents the **maximum recommended weekly limit** for both men and women in the UK to keep health risks low.- While a target for reduction for this patient, it does not reflect his current actual intake of **12 pints** per week.*24 units*- This value would imply that each pint contains exactly **2 units**, which is not accurate for a 4.5% ABV beer.- A pint of 4.5% ABV beer is actually **2.556 units**, making 12 pints total **30.6 units**.*36 units*- This figure would suggest an incorrect calculation where each pint is assumed to be **3 units**, which is typically associated with stronger beers (around 5.3% ABV).- Using the precise **4.5% ABV** given, the correct calculation yields **30.6 units**.*42 units*- This value would result from assuming approximately **3.5 units per pint**, which is characteristic of much stronger lagers or ciders (around 6% ABV).- The accurate calculation based on the specified **4.5% ABV** confirms the patient's intake is **30.6 units**.

Question 7: A 31-year-old woman attends with her cervical screening result showing hrHPV positive with low-grade dyskaryosis. She is 8 weeks pregnant with her second child. She had a normal screening result 3 years ago. What is the most appropriate management?

A. Refer for colposcopy after delivery and postnatal period (Correct Answer)
B. Refer for colposcopy within 6 weeks
C. Refer for immediate colposcopy before 12 weeks gestation
D. Repeat cervical screening at 28 weeks gestation
E. Defer all cervical screening until 12 weeks postpartum

Explanation: ***Refer for colposcopy after delivery and postnatal period*** - In the UK screening program, **low-grade dyskaryosis** and **hrHPV positivity** during pregnancy are managed by deferring colposcopy until at least **12 weeks postpartum**. - This delay is appropriate as **CIN1** (low-grade) carries a very low risk of progression to malignancy during gestation, and physiological changes like **cervical eversion** make interpretation difficult and increase risks. *Refer for colposcopy within 6 weeks* - Immediate or urgent referral within 6 weeks is reserved for **high-grade dyskaryosis** or clinical suspicion of **invasive cancer** where a timely biopsy is necessary. - For low-grade changes, the physical changes of the cervix in pregnancy increase the risk of **procedural bleeding** and diagnostic inaccuracy without significant clinical benefit. *Refer for immediate colposcopy before 12 weeks gestation* - There is no clinical indication for immediate colposcopy for **low-grade cytological abnormalities** in a pregnant patient, especially with a previously normal screening history. - Avoiding invasive procedures in the **first trimester** is generally preferred unless life-threatening pathology, such as suspected **invasive carcinoma**, is present. *Repeat cervical screening at 28 weeks gestation* - Repeating cervical screening during pregnancy is generally not recommended because **hormonal influences** and **decidualization** of the stroma can often lead to difficulty in cytological interpretation. - A repeat test would likely yield ambiguous results and would not alter the management plan, which is to await the **postpartum period** for definitive assessment. *Defer all cervical screening until 12 weeks postpartum* - This option is incorrect because the patient has **already had the test** and received an abnormal result; the question concerns the management of this specific **abnormal finding**. - While women are often advised to defer a *routine* screen until postpartum, an abnormal result requires management according to the appropriate **clinical pathway**, not just general deferral.

Question 8: A 64-year-old man returns for discussion of his NHS bowel cancer screening result. His FIT result is 78 µg Hb/g faeces. He has no symptoms, no family history of colorectal cancer, and examination is unremarkable. He takes aspirin 75 mg daily for previous myocardial infarction. What is the most appropriate management?

A. Reassure and repeat FIT in 2 years as part of routine screening
B. Stop aspirin for 2 weeks and repeat FIT test
C. Refer for colonoscopy via the screening programme (Correct Answer)
D. Arrange urgent suspected cancer (2-week wait) referral to gastroenterology
E. Arrange faecal calprotectin test to exclude inflammatory bowel disease

Explanation: ***Refer for colonoscopy via the screening programme*** - A **FIT result of 78 µg Hb/g faeces** is above the threshold for a positive screening result within the **NHS Bowel Cancer Screening Programme**, requiring urgent investigation. - A positive screening test mandates referral for a **colonoscopy** directly through the dedicated **screening programme pathway** to identify or exclude colorectal cancer or significant polyps. *Reassure and repeat FIT in 2 years as part of routine screening* - Reassurance is inappropriate given the **positive FIT result**, which indicates potential gastrointestinal bleeding that requires immediate investigation. - Delaying investigation for two years would constitute a **missed opportunity** to diagnose and treat early-stage colorectal cancer or high-risk adenomas. *Stop aspirin for 2 weeks and repeat FIT test* - **Aspirin** typically does not need to be stopped before a FIT test; while it can cause bleeding, a positive result still necessitates investigation for more serious pathology. - Stopping aspirin and repeating the test would introduce an **unnecessary delay** and does not reliably exclude underlying colorectal cancer or significant polyps. *Arrange urgent suspected cancer (2-week wait) referral to gastroenterology* - The **2-week wait (2WW) pathway** is primarily designed for symptomatic patients with a GP-initiated suspicion of cancer, not for asymptomatic individuals with a positive screening test. - Patients with positive screening results are managed through the **dedicated Bowel Cancer Screening Programme pathway**, which provides its own specific and timely colonoscopy referral system. *Arrange faecal calprotectin test to exclude inflammatory bowel disease* - **Faecal calprotectin** is used to differentiate between inflammatory bowel disease and irritable bowel syndrome in symptomatic patients, and has no role in the workup of a **positive FIT screening result**. - Pursuing a calprotectin test would be a **diagnostic misdirection** and would delay the crucial investigation for colorectal cancer or polyps.

Question 9: A 58-year-old woman attends for NHS Health Check. She has a BMI of 28 kg/m², BP 128/82 mmHg, and smokes 10 cigarettes daily. Bloods show total cholesterol 5.2 mmol/L, HDL 1.4 mmol/L, HbA1c 39 mmol/mol. Her QRISK3 score is 8.5%. She is motivated to improve her health. What is the most evidence-based lifestyle intervention to offer?

A. Smoking cessation support with varenicline or combination NRT (Correct Answer)
B. Exercise programme targeting 150 minutes moderate activity per week
C. Weight loss programme targeting 5-10% body weight reduction
D. Mediterranean diet advice with emphasis on reducing saturated fat
E. Combined lifestyle intervention addressing all modifiable risk factors

Explanation: ***Smoking cessation support with varenicline or combination NRT***- Smoking cessation provides the **single greatest reduction** in cardiovascular risk and overall mortality compared to any other modifiable risk factor intervention.- According to **NICE guidelines (NG92)**, the gold standard for smoking cessation is combining **behavioral support** with pharmacotherapy like varenicline or combination NRT, which significantly reduces CV risk. *Exercise programme targeting 150 minutes moderate activity per week*- While physical activity improves metabolic health and reduces **QRISK3 profiles**, it does not match the magnitude of **mortality reduction** seen with quitting tobacco.- Physical activity is a foundational recommendation, but it is considered secondary to **direct toxin elimination** in a current smoker. *Weight loss programme targeting 5-10% body weight reduction*- The patient’s BMI (28 kg/m²) is classified as **overweight** rather than obese, making weight loss less clinically urgent than addressing her **smoking status**.- Weight loss primarily targets **HbA1c and BP control**, but her levels of these markers are currently within or near acceptable ranges. *Mediterranean diet advice with emphasis on reducing saturated fat*- A **Mediterranean diet** is recommended for primary prevention of CVD, but it does not address the acute **thrombogenic and inflammatory** risks posed by active smoking.- Her lipid profile (Total Cholesterol 5.2, HDL 1.4) is relatively stable, meaning dietary changes would yield **smaller incremental gains** in survival. *Combined lifestyle intervention addressing all modifiable risk factors*- While all factors are important, evidence-based practice requires **prioritizing the intervention** with the highest impact; splitting focus may dilute the efficacy of **tobacco cessation**.- Smoking cessation is the most **cost-effective and clinically significant** individual intervention for a patient with a QRISK3 score below the 10% statin threshold.

Question 10: A 67-year-old man with type 2 diabetes for 15 years attends for review. His diabetic retinopathy screening report shows 'moderate non-proliferative diabetic retinopathy with diabetic maculopathy' in both eyes. His HbA1c is 68 mmol/mol and BP 142/86 mmHg. What is the most appropriate action regarding his eye care?

A. Increase screening frequency to 6 months
B. Continue annual diabetic eye screening
C. Refer to ophthalmology for assessment within 6 weeks (Correct Answer)
D. Arrange urgent ophthalmology referral within 2 weeks
E. Refer to optometry for visual acuity assessment

Explanation: ***Refer to ophthalmology for assessment within 6 weeks*** - The presence of **diabetic maculopathy** on screening is a "referable" condition that requires specialist assessment by an **ophthalmologist** within a 6-week timeframe. - **Maculopathy** is identified by features such as exudates or retinal thickening within **one disc diameter** of the fovea and can lead to severe central vision loss if not addressed with treatments like **anti-VEGF injections**. *Increase screening frequency to 6 months* - Increasing screening frequency is typically reserved for cases of **pre-proliferative (moderate/severe) retinopathy** without maculopathy, but it is insufficient when macroscopic macular changes are present. - Once **maculopathy** is detected, the patient moves out of the standard screening program and into the **Hospital Eye Service** for management. *Continue annual diabetic eye screening* - **Annual screening** is appropriate for patients with no or only mild non-proliferative retinopathy (background retinopathy) without macular involvement. - Maintaining a yearly schedule in this patient would risk permanent vision loss due to the failure to treat active **macular edema** or exudation. *Arrange urgent ophthalmology referral within 2 weeks* - A **2-week urgent referral** is reserved for **proliferative diabetic retinopathy** (new vessel formation), vitreous hemorrhage, or sudden, unexplained loss of vision. - **Moderate non-proliferative retinopathy** with maculopathy is considered serious but typically does not meet the criteria for emergency/urgent 2-week fast-track unless vision-threatening proliferative changes are noted. *Refer to optometry for visual acuity assessment* - While visual acuity is important, an **optometrist** cannot provide the specialized medical treatments (like laser or intravitreal drugs) required for **diabetic maculopathy**. - Clinical guidelines mandate a direct referral to **Ophthalmology** (secondary care) rather than optometry for any patient identified with referable retinopathy on screening.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free